Causes of death among commercially insured multiple sclerosis patients in the United States

Douglas S Goodin1, Michael Corwin2, David Kaufman3

  • 1Department of Neurology, University of California San Francisco, San Francisco, California, United States of America.

Plos One
|August 22, 2014
PubMed
Abstract

Insights

Multiple sclerosis (MS) patients experience higher mortality rates, primarily due to infections, cardiovascular, and pulmonary issues. Understanding these causes of death (CODs) can improve patient care and outcomes.

Area of Science:

  • Neurology
  • Public Health
  • Epidemiology

Background:

  • Information on causes of death (CODs) in multiple sclerosis (MS) patients is limited.
  • Prior research suggests MS patients have higher mortality from infectious, cardiovascular, or pulmonary causes.

Purpose of the Study:

  • To analyze disease categories leading to death in MS patients.
  • To gain insight into the pathways directly causing mortality in MS.

Main Methods:

  • Matched 30,402 MS patients to 89,818 non-MS comparators (1996-2009).
  • Utilized an algorithm to determine the principal cause of death (COD) from death certificates, minimizing bias towards MS or cardiac/pulmonary arrest.
  • Categorized principal CODs into MS, cancer, cardiovascular, infectious, suicide, accidental, pulmonary, other, or unknown.

Main Results:

  • MS patients had higher mortality rates (899 vs. 446 deaths/100,000 person-years).
  • Excess mortality in MS was mainly due to infections (43.2% pulmonary infections, 47.4% sepsis) and pulmonary causes (58.7% aspiration).
  • Cardiovascular causes contributed significantly to excess deaths, but no single entity predominated.

Conclusions:

  • The principal COD algorithm offers improved accuracy for determining mortality in MS patients.
  • Increased awareness of common CODs in MS can help physicians anticipate complications and enhance patient care.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
16
Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...
39
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
383
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.2K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.6K
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
41